WHO Dance! Board Takes Physical Exercise Breaks Between Sessions 29/01/2019 David Branigan & Catherine Saez The World Health Organization Executive Board meeting consists of many lengthy and arduous sessions. In the spirit of increasing physical activity to address non-communicable diseases - and possibly help delegates move to successful conclusions - here is a glimpse of a WHO physical exercise break from this week, set to a Chinese dance video. Continue reading -> WHO Board Looks Into Means To Reach Polio-Free World 28/01/2019 Catherine Saez Poliomyelitis, a highly infectious and sometimes debilitating viral disease, is about to be eradicated from the world. However, the last mile is the hardest, World Health Organization Director General Tedros Adhanom Ghebreyesus said last week at a member state discussion on polio eradication. Beyond the direct eradication of wild polioviruses in the three last endemic countries, and the steady supply of affordable inactivated poliovirus vaccines, the WHO is being called on to help countries keep the virus at bay, and implement a strategy to use polio-related structures to strengthen their national health systems, as polio funding is dwindling. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> First WHO Global Coordination Meeting On NCDs Sets Actions For Future 07/11/2018 Catherine Saez According to the World Health Organization, noncommunicable diseases (NCDs) - or chronic diseases - including cancer, cardiovascular diseases, and diabetes, kill 41 million people each year and are on the rise in developing countries. This week, the WHO held the first general meeting of its mechanism aiming at facilitating prevention and control of NCD diseases. The numerous speakers shared local, regional, and international experiences in implementing measures. Separately, WHO announced the launch of a new collaborative platform for NCDs. Continue reading -> Investing In New Antibiotic Research: Difficult Equation Discussed At World Investment Forum 26/10/2018 Catherine Saez The diminishing arsenal of efficient antibiotics to fight bacteria is a threat denounced by many, but investment in research and development of new antibiotics is seen as lagging. As the danger of getting back to a pre-antibiotic age is increasing, alternative ways of financing new antibiotics are being discussed. At the World Investment Forum this week, a panel looked into innovative means of investment, and ways to attract private investors to this field. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Board Looks Into Means To Reach Polio-Free World 28/01/2019 Catherine Saez Poliomyelitis, a highly infectious and sometimes debilitating viral disease, is about to be eradicated from the world. However, the last mile is the hardest, World Health Organization Director General Tedros Adhanom Ghebreyesus said last week at a member state discussion on polio eradication. Beyond the direct eradication of wild polioviruses in the three last endemic countries, and the steady supply of affordable inactivated poliovirus vaccines, the WHO is being called on to help countries keep the virus at bay, and implement a strategy to use polio-related structures to strengthen their national health systems, as polio funding is dwindling. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> First WHO Global Coordination Meeting On NCDs Sets Actions For Future 07/11/2018 Catherine Saez According to the World Health Organization, noncommunicable diseases (NCDs) - or chronic diseases - including cancer, cardiovascular diseases, and diabetes, kill 41 million people each year and are on the rise in developing countries. This week, the WHO held the first general meeting of its mechanism aiming at facilitating prevention and control of NCD diseases. The numerous speakers shared local, regional, and international experiences in implementing measures. Separately, WHO announced the launch of a new collaborative platform for NCDs. Continue reading -> Investing In New Antibiotic Research: Difficult Equation Discussed At World Investment Forum 26/10/2018 Catherine Saez The diminishing arsenal of efficient antibiotics to fight bacteria is a threat denounced by many, but investment in research and development of new antibiotics is seen as lagging. As the danger of getting back to a pre-antibiotic age is increasing, alternative ways of financing new antibiotics are being discussed. At the World Investment Forum this week, a panel looked into innovative means of investment, and ways to attract private investors to this field. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> First WHO Global Coordination Meeting On NCDs Sets Actions For Future 07/11/2018 Catherine Saez According to the World Health Organization, noncommunicable diseases (NCDs) - or chronic diseases - including cancer, cardiovascular diseases, and diabetes, kill 41 million people each year and are on the rise in developing countries. This week, the WHO held the first general meeting of its mechanism aiming at facilitating prevention and control of NCD diseases. The numerous speakers shared local, regional, and international experiences in implementing measures. Separately, WHO announced the launch of a new collaborative platform for NCDs. Continue reading -> Investing In New Antibiotic Research: Difficult Equation Discussed At World Investment Forum 26/10/2018 Catherine Saez The diminishing arsenal of efficient antibiotics to fight bacteria is a threat denounced by many, but investment in research and development of new antibiotics is seen as lagging. As the danger of getting back to a pre-antibiotic age is increasing, alternative ways of financing new antibiotics are being discussed. At the World Investment Forum this week, a panel looked into innovative means of investment, and ways to attract private investors to this field. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
First WHO Global Coordination Meeting On NCDs Sets Actions For Future 07/11/2018 Catherine Saez According to the World Health Organization, noncommunicable diseases (NCDs) - or chronic diseases - including cancer, cardiovascular diseases, and diabetes, kill 41 million people each year and are on the rise in developing countries. This week, the WHO held the first general meeting of its mechanism aiming at facilitating prevention and control of NCD diseases. The numerous speakers shared local, regional, and international experiences in implementing measures. Separately, WHO announced the launch of a new collaborative platform for NCDs. Continue reading -> Investing In New Antibiotic Research: Difficult Equation Discussed At World Investment Forum 26/10/2018 Catherine Saez The diminishing arsenal of efficient antibiotics to fight bacteria is a threat denounced by many, but investment in research and development of new antibiotics is seen as lagging. As the danger of getting back to a pre-antibiotic age is increasing, alternative ways of financing new antibiotics are being discussed. At the World Investment Forum this week, a panel looked into innovative means of investment, and ways to attract private investors to this field. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Investing In New Antibiotic Research: Difficult Equation Discussed At World Investment Forum 26/10/2018 Catherine Saez The diminishing arsenal of efficient antibiotics to fight bacteria is a threat denounced by many, but investment in research and development of new antibiotics is seen as lagging. As the danger of getting back to a pre-antibiotic age is increasing, alternative ways of financing new antibiotics are being discussed. At the World Investment Forum this week, a panel looked into innovative means of investment, and ways to attract private investors to this field. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Statistics Show Cancer Burden Rising In The World, Lung Cancer Biggest Killer 12/09/2018 Catherine Saez Cancer is rising and is expected to become the leading cause of global deaths in the 21st century, according to experts from a World Health Organization research agency on cancer. Lung cancer is the most common and the leading cause of cancer deaths, the agency found in its newly published study, the first since 2012. However, political commitment lags behind when it comes to prevention, speakers said at a press briefing at the UN in Geneva today. Continue reading -> European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Health Institutions Explore Measures To Curb Medicines Shortages In The EU 30/08/2018 Catherine Saez As many voices in Europe are getting louder about the increasing threat of medicines shortages, the European Medicines Agency and the Heads of Medicines Agencies task force on improving the availability of medicines in Europe just released its 2019/2020 work programme. Working groups tasked to tackle specific issues as well as a multi-stakeholder workshop in November are being set up. Continue reading -> Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Study Shows Pharmaceutical Industry Investing In Basic Research, Some Questions Remain Open 12/07/2018 Catherine Saez Basic research in health is often conducted by public universities or institutions, and public health activists have underlined the view that because research is funded by public money, medicines should not be so highly priced. A new study by an independent economic research institute shows that the pharmaceutical industry is a substantial partner in research activities and its investment in basic research is growing. The study, however, falls short of providing answers to key questions such as what is included in research and development figures, or what kind of basic research is conducted. Continue reading -> Posts navigation Older postsNewer posts